Best Er Positive Breast Cancer Podcasts (2025)

1
258. From Diagnosis to Downward Dog How Yoga Can Heal with Kate Garcia and Jen Tipton 38:23

6d ago38:23

38:23

Love the episode? Send us a text! In the podcast episode, I speak with Kate Garcia and Jen Tipton, and discuss the significant role that yoga can play in the lives of breast cancer survivors and thrivers. Both Kate and Jen lead yoga classes for our SurvivingBreastCancer.org (SBC) community and they share their personal experiences and insights on h…

1
Breast Cancer — Year in Review Series on Relevant New Datasets and Advances 59:31

11d ago59:31

59:31

Dr Rebecca Dent from National Cancer Centre Singapore and Dr Nancy Lin from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss important efficacy and safety data from 2024 related to the management of localized and advanced breast cancers. CME information and select publications here.By Dr. Neil Love

1
When ESR1 Mutations Arise in Breast Cancer Patients With PIK3CA Mutations: What Next? 10:15

11d ago10:15

10:15

The approach to ESR1 and PIK3CA mutations in patients with hormone receptor–positive metastatic breast cancer continues to evolve. What role does circulating tumor DNA (ctDNA) play in treatment decisions? How should oncologists best approach patients with PIK3CA mutations who subsequently develop ESR1 mutations? VK Gadi, MD, PhD, professor and dire…

1
257. What is Oncofertility? How To Navigate Genetics Fertility and Cancer Care 50:21

13d ago50:21

50:21

Love the episode? Send us a text! In this episode of Breast Cancer Conversations, I, Laura Carfing, founder of survivingbreastcancer.org, delve into the critical topic of fertility preservation and genetic counseling for breast cancer patients. Joined by Alejandra Bernal, a genetic counseling student at the University of Pittsburgh, and Melissa Bou…

1
256. Beyond the New Normal: Building Strength After Cancer Through Nutrition and Empowerment with Dr. Amy Morris 40:33

20d ago40:33

40:33

Love the episode? Send us a text! In this episode of Breast Cancer Conversations, host Laura Carfang welcomes Dr. Amy Morris, an ovarian cancer survivor and cancer researcher, to discuss navigating health and wellness post-cancer diagnosis. We delve into essential topics such as the side effects of treatments like chemotherapy, radiation, and hormo…

1
Oncology Nursing Edition: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress 1:33:02

21d ago1:33:02

1:33:02

Dr Edward B Garon, Dr Tiffany A Traina, and nurse practitioners Ms Marianne J Davies and Ms Marissa Marti-Smith discuss the role of antibody-drug conjugates in the care of patients with breast and lung cancer and strategies to mitigate and manage treatment-emergent adverse events. NCPD information and select publications here.…

1
Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy 52:52

22d ago52:52

52:52

Dr Adam M Brufsky from the University of Pittsburgh discusses first-line treatment selection for patients with HR-positive metastatic breast cancer and preexisting medical conditions. CME information and select publications here.By Dr. Neil Love

1
HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit 1:39:35

26d ago1:39:35

1:39:35

Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer.  CME information and select publications here.By Dr. Neil Love

1
How “Remarkable Change” in EGFR-Mutated NSCLC Care Is Making a Difference for Patients 12:30

26d ago12:30

12:30

The last few years have seen “a remarkable change in both our approach and management of EGFR lung cancer,” says Shirish M. Gadgeel, MD, division head for hematology/oncology and associate director of Patient Experience and Clinical Care at the Henry Ford Cancer Institute in Detroit. He discusses key considerations for managing EGFR-mutated non-sma…

1
Oncologists Urged to Discuss Fertility With Patients, as ASCO Updates Guidelines 10:24

1M ago10:24

10:24

When it comes to tackling fertility issues associated with cancer, “oncology clinicians are often reluctant to talk about this because it is really not our wheelhouse,” says Alison Wakoff Loren, MD, MSCE, chief of the Division of Hematology Oncology, director of Blood and Bone Marrow Transplantation, and the C. Willard Robinson Professor of Hematol…

1
“Second-Line ER-Positive Breast Cancer Has Just Become Very Complicated” 14:40

1M ago14:40

14:40

“Second-line [estrogen receptor (ER)]-positive breast cancer has just become very complicated,” says Erika P. Hamilton, MD, the director of breast cancer and gynecologic cancer research at Sarah Cannon Research Institute in Nashville. She discusses the role of ESR1 mutations in selecting appropriate treatments and combination regimens for patients …

1
HR-Positive Breast Cancer — Fourth Annual National General Medical Oncology Summit 1:59:29

1M ago1:59:29

1:59:29

Clinical investigators discuss available data guiding the management of hormone receptor-positive metastatic breast cancer. CME information and select publications here.By Dr. Neil Love

1
Breast Cancer — An Interview with Dr Adrienne G Waks on Recent Trial Updates 54:56

1M ago54:56

54:56

Dr Adrienne G Waks from Dana-Farber Cancer Institute in Boston, Massachusetts, reviews recent trial updates and their significance for the management of breast cancer. CME information and select publications here.By Dr. Neil Love

1
Will Generational Divide Among Oncologists Affect How AI Changes Cancer Care? 14:35

1M ago14:35

14:35

Burnout among oncologists is a serious concern, and artificial intelligence (AI) represents a potential solution, says Debra Patt, MD, PhD, MBA, a practicing oncologist and breast cancer specialist in Austin, Texas, who also serves as the chair of the AI task force for the American Society of Clinical Oncology. Technological advances are poised to …

1
“Time to Move On”: How Targeted Therapies Are Transforming AML Care 10:26

2M ago10:26

10:26

The standard approach of “7 + 3” chemotherapy in acute myeloid leukemia (AML) treatment has been in place for 50 years. But that may soon change, says Maximilian Stahl, MD, a member of the Adult Leukemia Group at the Dana-Farber Cancer Institute in Boston and a member of the faculty at Harvard University. “My prediction is that in 10 years, you wil…

1
Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel 49:28

2M ago49:28

49:28

Dr Christopher L Moertel from the University of Minnesota in Minneapolis discusses the clinical presentation of and optimal management strategies for plexiform neurofibromas and malignancies associated with neurofibromatosis type 1. CME information and select publications here.By Research to Practice

1
HR-Positive Breast Cancer — An Interview with Dr Sara A Hurvitz on the Role of Endocrine-Based Therapy 1:03:10

2M ago1:03:10

1:03:10

Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, summarizes data presented at the recent 2024 San Antonio Breast Cancer Symposium applicable to the management of HR-positive breast cancer. CME information and select publications here.By Research to Practice

1
5-Minute Journal Club Issue 6 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer 16:10

2M ago16:10

16:10

Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer. CME information and select publications here.By Research to Practice

1
Localized Breast Cancer — Examining the Current Use of Genetic Testing and Related Clinical Management 59:43

2M ago59:43

59:43

Dr Kevin S Hughes from the Medical University of South Carolina in Charleston and Dr Mark Robson from Memorial Sloan Kettering Cancer Center in New York discuss current BRCA1/2 genetic testing practices and the clinical management of localized breast cancer with alterations in these genes. CME information and select publications here.…

1
255. My Mom and I Were Diagnosed With Breast Cancer In The Same Year | With Kathleen Moss 46:28

2M ago46:28

46:28

Love the episode? Send us a text! In this episode of Breast Cancer Conversations, I had the pleasure of speaking with Kathleen Moss, a nutritionist from Portland, Oregon, who shared her journey with breast cancer. Kathleen's story is both unique and insightful, as she was diagnosed with lobular breast cancer after a decade of screening and monitori…

1
5-Minute Journal Club Issue 5 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer 18:31

2M ago18:31

18:31

Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer. CME information and select publications here.By Research to Practice

1
ASCO President Speaks Out on “Huge Problem” of Oncologist Burnout 14:51

3M ago14:51

14:51

Oncologist burnout and career dissatisfaction are a “huge problem,” says Robin T. Zon, MD, president of the American Society of Clinical Oncology (ASCO). Dr. Zon sits down with Robert A. Figlin, MD, the Steven Spielberg Family Chair in Hematology-Oncology at the Cedars-Sinai Cancer Center in Los Angeles, to discuss revelations from a recent ASCO re…

1
HER2-Low and HER2-Ultralow Breast Cancer — A Roundtable Discussion on Current and Future Management Strategies 2:02:17

3M ago2:02:17

2:02:17

Dr Joyce O’Shaughnessy from Sarah Cannon Research Institute in Dallas, Texas, Dr Mark D Pegram from Stanford Cancer Institute in California, and Prof Peter Schmid from Barts Cancer Institute in London, United Kingdom, summarize currently available data guiding treatment decision-making for patients with low and ultralow HER2 expression and present …

1
5-Minute Journal Club Issue 4 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer 10:06

3M ago10:06

10:06

Dr Seth Wander from Massachusetts General Hospital in Boston discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer. CME information and select publications hereBy Research to Practice

1
5-Minute Journal Club Issue 3 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer 11:58

4M ago11:58

11:58

Dr Seth Wander from Massachusetts General Hospital in Boston discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer. CME information and select publications hereBy Research to Practice

1
Oncologists Overtreat Patients at End of Life 10:45

4M ago10:45

10:45

When it comes to end-of-life care for patients with cancer, “I think that there is a real deficit in our training,” says Nathan I. Cherny, MD, director of the Cancer Pain and Palliative Medicine Service at Shaare Zedek Medical Center in Jerusalem, Israel. Dr. Cherney and colleagues recently examined factors contributing to oncologists overtreating …

1
254. Breast Cancer in Younger Women: Navigating Survivorship, Surgery Choices, and Lymphedema with Dr. Kohli 42:17

4M ago42:17

42:17

Love the episode? Send us a text! In this episode of Breast Cancer Conversations, I had the pleasure of speaking with Dr. Kohli, the Director of Breast Surgery at Monmouth Medical Center in New Jersey. We delved into the multifaceted journey of breast cancer survivorship, emphasizing the importance of treating the whole person, not just the disease…

1
Metastatic Triple-Negative Breast Cancer — Oncology Q&A for Clinicians: Discussing Common Questions Posed by Patients 1:00:17

4M ago1:00:17

1:00:17

Dr Lisa A Carey from UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, and Dr Rita Nanda from the University of Chicago in Illinois address commonly asked questions from patients diagnosed with metastatic triple-negative breast cancer. CME information and select publications here…

1
Oncology Q&A for Patients with Metastatic Triple-Negative Breast Cancer 1:00:59

4M ago1:00:59

1:00:59

For this patient-focused webinar, medical oncologist Dr Neil Love is joined by Dr Lisa A Carey from the UNC Lineberger Comprehensive Cancer Center in Chapel Hill and Dr Rita Nanda from The University of Chicago to discuss the patient experience associated with the diagnosis and treatment of metastatic triple-negative breast cancer.…

1
253. Breast Reconstruction and Plastic Surgery Explained: Expert Insights from Dr. Thomas Francel 35:30

4M ago35:30

35:30

Love the episode? Send us a text! I had the pleasure of speaking with Dr. Thomas Francel, a plastic surgeon specializing in breast reconstruction. One of the key takeaways from our conversation was the importance of personalized care. Dr. Francel stressed that each patient's journey is unique, and decisions regarding reconstruction should be made b…

1
Metastatic Breast Cancer — San Antonio 2024 symposium series proceedings Part 3 2:01:00

4M ago2:01:00

2:01:00

Dr Erika Hamilton from the Sarah Cannon Research Institute in Nashville, Tennessee, Dr Kevin Kalinsky from the Winship Cancer Institute of Emory University in Atlanta, Georgia, Dr Ian E Krop from the Yale Cancer Center in New Haven, Connecticut, Dr Joyce O’Shaughnessy from the Sarah Cannon Research Institute in Dallas, Texas, and Dr Sara M Tolaney …

1
The Role of Endocrine-Based Therapy in the Management of Breast Cancer — San Antonio 2024 symposium series proceedings Part 2 2:00:37

4M ago2:00:37

2:00:37

Dr Matthew Goetz from Mayo Clinic Comprehensive Cancer Center in Rochester, Minnesota, Dr Sara Hurvitz from Fred Hutchinson Cancer Center in Seattle, Washington, Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, Virginia Kaklamani from UT Health San Antonio MD Anderson Cancer Center in Texas, and Dr Seth Wander fro…

1
HER2-Low and HER2-Ultralow Breast Cancer — San Antonio 2024 symposium series proceedings Part 1 1:31:29

5M ago1:31:29

1:31:29

Dr Aditya Bardia, Professor Giuseppe Curigliano, Dr Hope Rugo and Dr Antonio C Wolff share their perspectives on the management of HER2-low breast cancer and the potential role of emerging data from SABCS 2024.By Research to Practice

1
5-Minute Journal Club Issue 2 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer 11:59

5M ago11:59

11:59

Dr Seth Wander from Massachusetts General Hospital in Boston discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.By Research to Practice

1
FDA Approvals Change Practice for Metastatic Breast Cancer With PIK3CA Mutations 11:01

5M ago11:01

11:01

Recent advances in hormone receptor–positive, HER2-negative metastatic breast cancer have led to questions about the timing of genetic testing and the optimal treatment choices for patients. “I, like many others, have changed my personal practice,” says Azka Ali, MD, a medical oncologist at the Cleveland Clinic Taussig Cancer Institute in Ohio. She…

1
252. What is Energy Medicine with Inflammatory Breast Cancer Survivor Dianne Faure 41:48

5M ago41:48

41:48

Love the episode? Send us a text! In this episode of Breast Cancer Conversations, I had the pleasure of speaking with Dianne Faure, an attorney, author, teacher, advanced Eden energy medicine practitioner, and massage therapist. Dianne shared her incredible journey of using energy medicine to manage and overcome various health issues, including her…

1
Exploring the Current Management Paradigm for Patients with Metastatic Triple-Negative Breast Cancer 59:42

5M ago59:42

59:42

Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood and Dr Sara M Tolaney from Dana-Farber Cancer Center in Boston discuss recent updates on available and novel treatment strategies for metastatic triple-negative breast cancer.By Research to Practice

1
5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer 10:56

6M ago10:56

10:56

Dr Seth Wander from Massachusetts General Hospital in Boston discusses recent developments with oral selective estrogen receptor degraders for ER-positive metastatic breast cancer.By Research to Practice

1
251. The Power of Storytelling in Breast Cancer: Lessons from Cancer Bitch Author S.L. Wisenberg 44:42

6M ago44:42

44:42

Love the episode? Send us a text! In this episode of Breast Cancer Conversations, I had the pleasure of speaking with S.L. Wisenberg, a self-described "one-breasted feminist" and author of "The Adventures of Cancer Bitch." S.L. shared her journey of being diagnosed with stage 2A breast cancer in 2007, undergoing a mastectomy and chemotherapy, and h…

1
Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities 56:49

6M ago56:49

56:49

Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Hope S Rugo from the UCSF Helen Diller Family Comprehensive Cancer Center discuss treatment decision-making for HR-positive metastatic breast cancer in patients who harbor PI3K/AKT/PTEN pathway mutations.By Research to Practice

1
250. Redefining Palliative Care and The Role of Supportive Care in Cancer Treatment with Dr. Janet Abrahm 53:32

6M ago53:32

53:32

Love the episode? Send us a text! Dr. Janet Abrahm reshapes the common perception of palliative care, emphasizing that it should not be viewed solely as end-of-life support, but rather as an essential form of supportive care that can significantly improve patient outcomes and quality of life when integrated early. With over 20 years of experience a…

1
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Breast Cancer 1:03:53

6M ago1:03:53

1:03:53

Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with HR-positive breast cancer.By Research to Practice

1
To Help Oncologists’ Burnout, Should Primary Care Take on More Burden? 11:18

6M ago11:18

11:18

The European Society for Medical Oncology (ESMO) Resilience Task Force recently released recommendations intended to reduce burnout in oncology worldwide. One of the task force’s members, Konstantinos Kamposioras, MD, PhD, a consultant in medical oncology at the Christie NHS Foundation Trust in Manchester in the United Kingdom, explains to Robert A…

1
Choosing Between an “Old Friend” and New Ones in EGFR-Mutated Metastatic NSCLC 12:50

6M ago12:50

12:50

When it comes to the treatment of EGFR-mutated metastatic non-small cell lung cancer (NSCLC), osimertinib (Tagrisso) is an “old friend,” says Kamya Sankar, MD, assistant professor and co–medical director of the Thoracic Disease Research Group at Cedars-Sinai Cancer Center in Los Angeles. Recent approvals by the U.S. Food and Drug Administration hav…

1
rivatization of Cancer Clinical Research Raises Concerns for Practice 13:09

6M ago13:09

13:09

“Cancer clinical research has been largely privatized,” explains Joseph Unger, PhD, MS, associate professor in the cancer prevention program at the Fred Hutchinson Cancer Center in Seattle. Dr. Unger and colleagues recently assessed patient enrollment in industry-sponsored and federally sponsored clinical trials. They found an 8:1 ratio favoring pa…

1
249. Preparing for Breast Cancer Surgery: What You Need to Know with Dr. Tammaro 48:35

7M ago48:35

48:35

Love the episode? Send us a text! Breast cancer is a deeply personal journey. As the landscape of breast cancer treatment evolves, understanding the surgical options available becomes crucial for patients navigating this challenging experience. In this episode, we speak with Dr. Yolanda Tamero, a breast surgical oncologist, who provides invaluable …

1
Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer 59:29

7M ago59:29

59:29

Prof Francois-Clement Bidard from Institut Curie in Paris and Dr Kevin Kalinsky from Winship Cancer Institute of Emory University in Atlanta discuss improving the outcomes of first-line endocrine-based therapy for patients with HR-positive, HER2-negative metastatic breast cancer.By Research to Practice

1
What 3 Big Trials Mean for Breast Cancer Practice 12:48

7M ago12:48

12:48

Treatment approaches for patients with hormone receptor (HR)-positive, HER2-negative breast cancer have rapidly evolved, thanks in part to data from three key studies. Erin Frances Cobain, MD, associate professor at the University of Michigan Rogel Cancer Center in Ann Arbor, explains how findings from the KEYNOTE-756, monarchE, and NATALEE clinica…

1
248. Enhancing Patient-Provider Communication in Breast Cancer Care with Stephanie S. Abbott 48:58

7M ago48:58

48:58

Love the episode? Send us a text! In this episode of Breast Cancer Conversations, I had the pleasure of speaking with Stephanie S. Abbott, a remarkable individual who has navigated the complex worlds of both healthcare administration and cancer survivorship. Stephanie brings a unique perspective, having served in multiple leadership roles in health…

1
Oncology Today with Dr Neil Love: Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer 45:46

7M ago45:46

45:46

Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville discusses emerging evidence with proteolysis-targeting chimera estrogen receptor degraders for HR-positive metastatic breast cancer.By Research to Practice

Podcasts Worth a Listen

Er Positive Breast Cancer Podcasts

Podcasts Worth a Listen